C.M. Bidwell & Associates’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-273,804
Closed -$8.45M 282
2016
Q4
$8.45M Buy
+273,804
New +$8.15M 1.99% 7

Other funds holding QGEN

C.M. Bidwell & Associates's QGEN Position: Q1 2017 in Review

C.M. Bidwell & Associates sold out of Qiagen (QGEN) in Q1 2017, closing a stake of 273,804 shares — an estimated $8.45M sold.

C.M. Bidwell & Associates first reported a position in QGEN in Q4 2016 and held it in 1 quarter. The position peaked at $8.45M in Q4 2016. 183 funds tracked by Wall St. Rank hold QGEN as of Q1 2017.

  • C.M. Bidwell & Associates reported no remaining Qiagen position as of Q1 2017 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 273,804 Qiagen shares in Q1 2017, an estimated $8.45M.
  • C.M. Bidwell & Associates first reported a position in Qiagen in Q4 2016 and held it in 1 quarter.
  • C.M. Bidwell & Associates's Qiagen position peaked at $8.45M in Q4 2016.
  • 183 funds tracked by Wall St. Rank held Qiagen as of Q1 2017.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2017, filed 12 May 2017.